Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Effect of lidocaine on neuromuscular blockade by mivacurium chloride
ChiCTR2400079619Phase 4Not yet recruiting
- Sponsor
- The Second Affiliated Hospital and Yuying Children's Hospital of Wenzhou Medical University
- Start
- Jan 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial of lidocaine in ureterolithiasis and nephrolithiasis (2 arms), sponsored by The Second Affiliated Hospital and Yuying Children's Hospital of Wenzhou Medical University. Primary endpoints: Onset time of neuromuscular blockade, Clinical duration of neuromuscular blockade and 1 more. Planned start Jan 2024; status: not yet recruiting.
02
Drugs
lidocaine
03
Conditions
ureterolithiasisnephrolithiasis
Beyond the preview
Go deeper on ChiCTR2400079619.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2400079619.